Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

The effect of ciclotropium on human heart rate

Abstract

Ciclotropium is a recently developed parasympathicolytic agent. Plasma concentration and heart rate increase (the most prominent anticholinergic effects) were measured in 12 healthy subjects before, during and after a 15-min intravenous infusion of 10 mg ciclotropium. The effect was described by using either a linear or a nonlinear (E max) effect model linked to a linear three-compartment kinetic model via an effect compartment.

Maximum heart rate increase was 33 (10) beats·min−1, and half-value duration of effect was 41 (9) min. Total plasma clearance was 0.51 (0.13) l·min−1, and mean terminal elimination half-life was 12 (4) h, whereas the equilibration half-lives of drug removal from the effect compartment ranged from 2 to 14 min.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Möller J, Rosen A (1968) Comparative studies on intramuscular and oral effective doses of some anticholinergic drugs. Acta Med. Scand 184: 201–209

  2. 2.

    Schladitz-Keil G, Spahn H, Mutschler E (1986) Determination of the bioavailability of the quaternary compound trospium chloride in man from urinary excretion data. Drug Res 36: 984–987

  3. 3.

    Liebmann B, Ding RW, Weber E, Mutschler E, Spahn-Langguth H, Langguth P (1994) Pharmacokinetics of ciclotropium in humans: rate and extent of absorption after oral administration. Biopharm Drug Dispos (submitted for publication)

  4. 4.

    Hinderling PH, Gundert-Remy U, Schmidlin O, Heinzel G (1985) Integrated pharmacokinetics and pharmacodynamics of atropine in healthy humans. II. pharmacodynamics. J Pharm Sci 74: 711–717

  5. 5.

    Roberts JB, Breckenridge AM (1977) Drugs affecting autonomic functions. In: Dukes MNG (ed) Meyler's side effects of drugs, vol 8, 2nd edn. Excerpta Medica, Amsterdam, pp 304–330

  6. 6.

    Heuer H, Gülker H, Frenking B, Bender F (1983) Klinischelektrophysiologische Befunde zur Wirkung von Ciclotropiumbromid auf bradycarde Herzrhythmusstörungen. Z Kardiol 72 [Suppl 2]: 76

  7. 7.

    Liebmann B, Henke D, Spahn-Langguth H, Mutschler E (1991) Determination of the quaternary compound ciclotropium in human biological material after hydrolysis and derivatization with the fluorophor flunoxaprofen chloride. J Chromatogr 572: 181–93

  8. 8.

    Liebmann B, Mayer S, Mutschler E, Spahn-Langguth H (1992) Studies on the metabolic clearance of ciclotropium to α-phenylciclo-pentyl acetic acid using a new enantiospecific metabolite assay. Drug Res 42: 1354–1358

  9. 9.

    Benet LZ (1972) General treatment of linear mammilary models with elimination from any compartment as used in pharmacokinetics. J Pharm Sci 61: 536–541

  10. 10.

    Gibaldi M, Perrier D (1982) Pharmacokinetics, 2nd edn. Dekker, New York, p 93

  11. 11.

    Sheiner LB, Rosenberg B, Marathe VV (1977) Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 5: 445–479

  12. 12.

    Whiting B, Holford NHG, Sheiner LB (1980) Quantitative analysis of the disopyramide concentration-effect relationship. Br J Clin Pharmacol 9: 67–75

  13. 13.

    Holford NHG, Sheiner LB (1981) Understanding the dose-effect relationship: Clinical application of pharmacokinetic-pharmacodynamic models. Clin Pharmacokinet 6: 429–453

  14. 14.

    Holford NHG (1988) MKMODEL. An extended least squares modelling program. Biosoft, Cambridge, UK

  15. 15.

    Herxheimer A, Haefeli L (1966) Human pharmacology of hyoscine butylbromide. Lancet II: 418–421

  16. 16.

    Kalser SC, McLain PL (1969) Atropine metabolism in man. Clin Pharmacol Ther 11: 214–227

  17. 17.

    Kanto J, Klotz U (1988) Pharmacokinetic implications for the clinical use of atropine, scopolamine and glycopyrrolate. Acta Anaesthesiol Scand 32: 69–78

Download references

Author information

Correspondence to R. W. Ding.

Additional information

Died on 7 December 1992

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ding, R.W., Port, R.E., Ortmann, K. et al. The effect of ciclotropium on human heart rate. Eur J Clin Pharmacol 46, 455–459 (1994). https://doi.org/10.1007/BF00191911

Download citation

Key words

  • Ciclotropium
  • heart rate
  • pharmacokinetic/pharmacodynamic modelling
  • effect compartment